L.J Tan, M.S., Ph.D., is the chief strategy officer of the Immunization Action Coalition (IAC). Prior to joining the IAC, Dr. Tan was the director of medicine and public health at the American Medical Association (AMA) a position he held since 2008. From 1997 to 2008, he was the AMA’s director of infectious disease, immunology, and molecular medicine. Dr. Tan was a voting member of the Department of Health and Human Services’ National Vaccine Advisory Committee from 2009 to 2013, where he served on the adult immunization, vaccine safety, and healthcare worker immunization working groups, and chaired the immunization infrastructure working group. For more than ten years, he was the AMA’s liaison to the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, where he served on the influenza, pneumococcal, zoster, and adult immunization working groups. He co-founded and currently co-chairs the National Adult and Influenza Immunization Summit. He serves or has served on the steering committees/advisory boards of the 317 Coalition, the Adult Vaccine Access Coalition (AVAC), the Unity (United for Adolescent Vaccination) Consortium, the National Network for Immunization Information, and the National Viral Hepatitis Roundtable and on the IAC scientific advisory board. Dr. Tan has also serves, or has served, on the National Quality Forum’s Adult Immunizations Expert Committee, the Pharmacy Quality Alliance’s Adult Immunization Working Group, and numerous national and international expert and technical advisory committees, including panels for the Centers for Medicare and Medicaid Services, The Joint Commission, and the Centers for Disease Control and Prevention, on issues ranging from vaccine hesitancy, immunization quality measurement development, adult immunizations, to immunization access and delivery. In 2007, he founded the National Immunization Congress and organized its 2007 and 2010 meetings. Dr. Tan received his Master of Science degree in biology at New York University and earned his PhD in microbiology/immunology from Northwestern University Feinberg School of Medicine in Chicago. Dr. Tan is an editor for Vaccine, BMC Infectious Diseases, Medscape Infectious Diseases, and a member of the ESCMID Vaccine Study Group and has published more than 50 peer-reviewed articles. During his tenure at the AMA, he wrote numerous scientific reports to guide the association’s policies on a diverse range of public health topics. A skilled and sought-after speaker, Dr. Tan has been invited to address international, national, and state immunization audiences on issues ranging from vaccine financing to risk management in vaccine safety to emerging infectious diseases. Dr. Tan has received several awards for his advocacy work including the 2011 CDC National Center for Immunization and Respiratory Diseases Honor Awards: Excellence in Partnering recognition, and most recently was awarded the American Pharmacists Association’s national Friend of Pharmacy Award. As a former part-time faculty member at the Institute for Science Education and Science Communication, Columbia College, Chicago, he received the 2000 Excellence in Teaching Award.
Esther Krofah, MPP, is the executive director of FasterCures, a center of the Milken Institute. She has deep experience in the government, nonprofit, and for-profit sectors, where she has led efforts to bring together diverse stakeholder groups to solve critical issues and achieve shared goals that improve the lives of patients. Most recently, Krofah was the director of public policy leading GlaxoSmithKline’s engagement with the U.S. Department of Health and Human Services (HHS) and relevant Executive Branch agencies on broad health-care policy issues, including leadership in improving vaccinations and care for people living with HIV. Prior to GSK, Krofah served as the deputy director of HHS’ Office of Health Reform, where she led the development of policy positions for significant regulatory priorities, including the health insurance marketplaces. Prior to HHS, Krofah served as a program director at the National Governors Association (NGA) health-care division, working directly with governors’ health policy advisors, state Medicaid directors, and state health commissioners on health insurance, health workforce, and Medicaid coverage issues. Before joining the NGA, Krofah worked in consulting at Deloitte Consulting LLP, where she worked with public sector and commercial clients, including assisting states in developing state-based exchanges. Krofah received a B.A. from Duke University and a Master of Public Policy from the Harvard University John F. Kennedy School of Government.
Sarah J. Dash, MPH, is the president and chief executive officer at the Alliance for Health Policy. She drives the mission and vision of the Alliance, as well as advances and maintains the reputation of the organization as the leading nonpartisan resource for policymakers and health leaders in an evolving health policy environment. Sarah joined the Alliance in 2014 as the vice president for policy and became president and CEO in May 2017. Sarah has long been an influential force in shaping health policy, having served as a senior aide on Capitol Hill and as a member of the research faculty at the Georgetown University Health Policy Institute’s Center on Health Insurance Reforms. Sarah holds a master’s degree in public health from the Yale School of Public Health and a bachelor’s degree in chemistry and literature from MIT. Sarah also holds an Executive Certificate in Nonprofit Management from Georgetown University.